Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Duloxetine for the Treatment of Dysthymia.

Trial Profile

Duloxetine for the Treatment of Dysthymia.

Phase of Trial: Phase IV

Latest Information Update: 14 Apr 2009

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Dysthymic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Apr 2009 Actual end date (Apr 2006) added as reported by ClinicalTrials.gov.
    • 14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Apr 2009 Planned end date changed from 1 Apr 2006 to 1 Dec 2006 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top